Pharma Grade Sodium Bicarbonate Market is expected to reach US$ 256.0 million by 2022 and is projected to expand to US$ 315.4 million by 2028, with a robust CAGR of 3.5%.
In pharma grade, sodium bicarbonate (NaHCO3) is a white crystalline powder. It is manufactured through a thorough purification process that removes impurities and pollutants to provide the highest level of purity suited for medicinal applications. Because of its great purity, it is appropriate for use in pharmaceutical items and prescription compositions.
The global pharmaceutical business has made considerable breakthroughs throughout the years, ranging from groundbreaking medical discoveries to cutting-edge production procedures. Pharmaceutical grade sodium bicarbonate is one of the primary components that contribute to the pharmaceutical landscape. Pharma grade sodium bicarbonate is well-known for its numerous applications and strict purity standards, and it is widely utilized in pharmaceutical formulations, making it a market staple.
Don’t Miss Out – Grab Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-6826
Administering Sodium Bicarbonate to Pregnant Women Found Effective in Inducing Natural Childbirth
Researchers from the University of Liverpool and the Karolinska Institute in Sweden revealed that providing women in labor pharma grade sodium bicarbonate increased their chances of achieving a natural, vaginal delivery. A group of women received pharma grade sodium bicarbonate in addition to oxytocin, while another group received only oxytocin – a medication that helps strengthen contractions. It was shown that consuming bicarbonate of soda raised the chances of a vaginal delivery by 17% when compared to merely delivering oxytocin, which only assisted in very few situations, leaving emergency caesarean section as the only choice for the remaining cases. This type of therapeutic use of pharma grade sodium bicarbonate, according to researchers, will reduce Amniotic Fluid Lactate (AFL) – high levels.
Another study indicated that using pharma grade sodium bicarbonate as a supplement by young swimmers improved their performance by modulating blood buffering capacity. Athletes that took this chemical in controlled doses also showed lower levels of lactate concentration and digestive symptoms such as cramps and abdominal pain.
Developing Pharmaceutical Sector in Certain Countries Anticipated to Attract Huge Global Investments
Low cost treatments using pharma grade sodium bicarbonate have the potential to improve mortality rates in developing nations with a thriving pharmaceutical sector. This is projected to create traction in the global market for pharma grade sodium bicarbonate therapeutics. Additionally, favourable government policies including those pertaining to foreign direct investments, healthcare facilities and infrastructure development programmes such as cluster development in the pharmaceuticals sector are likely to trigger revenue growth of the global pharma grade sodium bicarbonate market.
The demand for pharmaceutical grade sodium bicarbonate is largely driven by increasing healthcare expenditure and rising demand for pharmaceutical products utilising sodium bicarbonate.
Get Answers to Report Queries: https://www.futuremarketinsights.com/ask-question/rep-gb-6826
Competition Landscape
Key players operating in the global pharma grade sodium bicarbonate market are focusing on new product launches in the form of injections for the medical industry worldwide. They are also engaging in collaborations, mergers, acquisitions, and joint ventures to distribute their products in numerous healthcare institutions to cater to the high demand from consumers. Meanwhile, some of the other companies are aiming to conduct exhaustive research and development activities to introduce innovative sodium bicarbonate medications for various disorders.
Key Companies Profiled
- Solvay SA
- Tata Chemicals
- Novacarb (Novacap Group)
- Dr. Paul Lohmann GmbH KG
- GHCL Limited
- CIECH S.A.
- Natural Soda LLC
- Jost Chemical Co.
- Tronox Alkali Corporation
Seize the Opportunity – Buy Report Now: https://www.futuremarketinsights.com/checkout/6826
Key Segmentation
By Application:
- API
- Excipients
- Antacids
- Haemodialysis
- Tablet Coating
- Toothpaste
- Others
By Grade:
- Fine
- Coarse
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- SEA and Pacific
- China
- India
- Japan
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
